Loading...
Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial
BACKGROUND: Neoadjuvant chemotherapy is a standard of care for patients with adenocarcinoma of the esophagus and stomach in Europe, but still only 20–40 % respond to therapy and the critical issue; how to treat nonresponding patients is still unclear. So far, there is no randomized trial evaluating...
Na minha lista:
| Udgivet i: | Pilot Feasibility Stud |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153833/ https://ncbi.nlm.nih.gov/pubmed/27965838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-016-0059-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|